| Titre : | Trends in Prostate-Specific Antigen Test Use, 2000-2005. (2011) |
| Auteurs : | ROSS (Louie-E) : USA. The Institute for Health. Social and Community Research. Shaw University. Raleigh. NC. ; HOWARD (Daniel-L) : USA. The Robert Wood Johnson Foundation Center for Health Policy. Meharry Medical College. Nashville. TN. ; TAYLOR (Yhenneko-J) : USA. Department of Public Health Sciences. University of North Carolina at Charlotte. Charlotte. NC. |
| Type de document : | Article |
| Dans : | Public health reports (vol. 126, n° 2, 2011) |
| Pagination : | 228-239 |
| Langues: | Anglais |
| Mots-clés : | Tendance séculaire ; Prostate ; Utilisation ; Appareil urogénital |
| Résumé : | [BDSP. Notice produite par INIST-CNRS R0xoHAnF. Diffusion soumise à autorisation]. Objective. This study examined prostate-specific antigen (PSA) test use among men and identified sociodemographic and health-related characteristics associated with its use over time. Methods. The National Health Interview Survey collected information on PSA test use among 16,058 men>=40 years of age in 2000 and 2005. We examined two outcomes : (1) having had a recent (within two years) screening PSA test and (2) having had three or more PSA tests in the past five years (to indicate frequent use). Results. Marital status, family history of prostate cancer, and having seen a doctor in the past year differed over time in the unadjusted model. In the adjusted model, recent PSA screening decreased from 2000 to 2005 for single, never-married men, but increased for men with chronic diseases. Frequent PSA test use increased for men with a family history of prostate cancer, men with chronic diseases, and men who had seen a physician in the past year. Significant correlates of higher recent PSA test use included being older, married, and of black race/ethnicity ; having higher levels of education and income, health-care coverage, and a usual place of health care ; and increased comorbidity. Conclusion. Major organizations are not in agreement about the efficacy of prostate cancer screening ; however, men>=40 years of age continue to use the PSA test. Both recent screening and frequent testing showed variability during the study period and may have implications for the ongoing randomized clinical trials that are expected to clarify whether early detection of prostate cancer with PSA testing increases survival. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact